Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01631747 · ClinicalTrials.gov registry record · NA

Maternal-Offspring Metabolics:Family Intervention Trial

A NA study of Pregnancy and Weight Gain, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
281
Enrollment target
2
Study locations

NCT01631747: Completed NA study of Pregnancy and Weight Gain, sponsored by Northwestern University.

NCT01631747 is a NA study of Pregnancy and Weight Gain that has completed, run by Northwestern University. The registered enrollment target is 281 participants, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (68% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01631747, a NA study of Pregnancy and Weight Gain, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
281 participants
Enrollment target
2
Study locations

Study Summary

The prevalence of maternal overweight and obesity has nearly doubled in the United States since 1976. In 2004-2005, 42% of pregnant women had body mass index (BMI) above 25 versus 23% in 1993. Most American women are overweight/ obese (OW/OB) at conception, especially within certain racial, ethnic, and lower socioeconomic groups leading to increased adverse maternal and birth outcomes. This study will recruit, randomize and test in 300 ethnically diverse OW/OB pregnant women a behavioral intervention aimed at controlling gestational weight gain (GWG) through recommended diet, activity and lifestyle changes that are to be maintained postpartum. Outcomes include anthropometric (height, weight, percent body fat) metabolic (blood pressure, fasting glucose, insulin, HbA1c, lipids and C-reactive protein) and behavioral measures (diet. physical activity, sleep and stress). In addition, babies will be measured for length, weight and percent body fat. The goal is to limit excessive gestational weight gain through improved maternal lifestyle that can be maintained and modelled for the family post partum and beyond.

Primary Outcome

The primary outcome is GWG as assessed continuously by the difference between the maternal weight measured at the baseline and at the 35-37 week visit.

Conditions Studied

Interventions

  • BEHAVIORAL Usual Care Group
  • BEHAVIORAL Lifestyle Intervention Group

Study Locations (2)

Illinois

  • Northwestern Memorial Hospital; Prentice Women's - Chicago
  • Northwestern University: Dept of Preventive Medicine - Chicago

Trial Details

FieldValue
Enrollment Target 281 participants
Start Date 2012-11
Est. Completion 2017-07-31
Phase NA
Northwestern University

1,209 total trials

What the finished NCT01631747 record still lists

NCT01631747 is an interventional study that assigns participants to a tested intervention. The registered 281 participants enrollment target is mid-sized for trials with a published cap, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (68% lower).

The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Usual Care Group is the first listed.

NCT01631747 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT01631747 about?

NCT01631747 is a clinical study titled "Maternal-Offspring Metabolics:Family Intervention Trial". The prevalence of maternal overweight and obesity has nearly doubled in the United States since 1976. In 2004-2005, 42% of pregnant women had body mass index (BMI) above 25 versus 23% in 1993. Most American women are overweight/ obese (OW/OB) at conception, especially within certain racial, ethnic, ...

What is the current status of trial NCT01631747?

This trial is currently completed. It is a NA study. The enrollment target is 281 participants. The study started on 2012-11. Estimated completion is 2017-07-31.

What conditions does trial NCT01631747 study?

This clinical trial studies the following conditions: Pregnancy, Weight Gain.

What interventions are being tested in trial NCT01631747?

The interventions under investigation include: Usual Care Group (BEHAVIORAL), Lifestyle Intervention Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT01631747?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01631747 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01631747's enrollment target sits among peer trials

281 77th of 191 higher than 115 of 191 other Pregnancy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04521231 · 281 participants · Phase 1

    A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

  • NCT06190730 · 281 participants · NA

    REmote Symptom COllection to improVE postopeRative Care

  • NCT02860364 · 282 participants · NA

    Comparing Hypothermic Temperatures During Hemiarch Surgery

  • NCT04867395 · 282 participants · NA

    A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01631747, the US trial registry maintained by the National Library of Medicine. NCT01631747 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.